• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Lung function in patients receiving busulphan.接受白消安治疗的患者的肺功能。
Br Med J. 1970 Nov 28;4(5734):530-2. doi: 10.1136/bmj.4.5734.530.
2
Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Scand J Respir Dis. 1972;53(5):265-73.
3
Busulphan lung.白消安肺
Thorax. 1969 Nov;24(6):639-55. doi: 10.1136/thx.24.6.639.
4
Busulphan lung in childhood.儿童白消安肺
J Clin Pathol. 1981 May;34(5):495-500. doi: 10.1136/jcp.34.5.495.
5
Busulphan lung.白消安肺
Med J Aust. 1972 Sep 23;2(13):719-22. doi: 10.5694/j.1326-5377.1972.tb103507.x.
6
[Busulfan-induced pneumopathy].
Rev Mal Respir. 1987;4(1):3-10.
7
Busulfan lung. Report of two cases and review of the literature.
Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):151-6. doi: 10.2214/ajr.120.1.151.
8
Busulphan lung: clinical features.白消安肺：临床特征
Thorax. 1970 Mar;25(2):257. doi: 10.1136/thx.25.2.257-a.
9
Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Am Rev Respir Dis. 1970 Mar;101(3):408-13. doi: 10.1164/arrd.1970.101.3.408.
10
[Myleran lung in chronic myelosis].[慢性粒细胞白血病中的马利兰肺]
Wien Z Inn Med. 1973;54(4):150-5.

引用本文的文献

1
Pulmonary hypertension associated with busulfan.与白消安相关的肺动脉高压
Pulm Circ. 2021 Sep 30;11(4):20458940211030170. doi: 10.1177/20458940211030170. eCollection 2021 Oct-Dec.
2
Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.小儿肿瘤患者中白消安诱导的肺损伤——文献综述及病例说明
Pediatr Allergy Immunol Pulmonol. 2019 Sep 1;32(3):86-91. doi: 10.1089/ped.2019.0990. Epub 2019 Sep 17.
3
The single-breath carbon monoxide transfer test 25 years on: a reappraisal. 2--Clinical considerations.单呼吸一氧化碳转运试验25年回顾：重新评估。2——临床考量
Thorax. 1983 Jan;38(1):5-9. doi: 10.1136/thx.38.1.5.
4
Lung damage from cytotoxic drugs.细胞毒性药物所致的肺损伤。
Cancer Chemother Pharmacol. 1980;4(1):17-27. doi: 10.1007/BF00255453.
5
Drug-induced respiratory disorders.药物性呼吸系统疾病
Br Med J. 1973 May 12;2(5862):320-1.
6
An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung.在一项针对肺癌切除术后使用白消安、环磷酰胺及安慰剂的对照试验中对胸部X光片的调查。
Thorax. 1976 Jun;31(3):265-70. doi: 10.1136/thx.31.3.265.

本文引用的文献

1
A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.一种与长期白消安（马利兰）治疗相关的类似肾上腺皮质功能不全的综合征。
Blood. 1961 Nov;18:497-510.
2
DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY.白消安治疗后弥漫性间质性肺纤维化
Lancet. 1963 Aug 31;2(7305):432-4. doi: 10.1016/s0140-6736(63)92173-1.
3
Interstitial pulmonary fibrosis following busulfan therapy.白消安治疗后发生的间质性肺纤维化。
Am J Med. 1961 Jul;31:134-9. doi: 10.1016/0002-9343(61)90229-7.
4
Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocortical insufficiency and atrophic bronchitis.白消安（马利兰）治疗后出现的细胞发育异常。一种类似肾上腺皮质功能不全和萎缩性支气管炎的综合征。
Ann Intern Med. 1965 Oct;63(4):654-60. doi: 10.7326/0003-4819-63-4-654.
5
Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Am Rev Respir Dis. 1970 Mar;101(3):408-13. doi: 10.1164/arrd.1970.101.3.408.
6
Busulphan lung.白消安肺
Thorax. 1969 Nov;24(6):639-55. doi: 10.1136/thx.24.6.639.
7
Busulphan and bone marrow depression.白消安与骨髓抑制
Br Med J. 1969 Mar 8;1(5644):638. doi: 10.1136/bmj.1.5644.638-a.
8
Busulphan lung.白消安肺
Thorax. 1968 Mar;23(2):187-93. doi: 10.1136/thx.23.2.187.
9
Two cases of busulfan toxicity.两例白消安毒性病例。
Ann Intern Med. 1966 Jan;64(1):154-64. doi: 10.7326/0003-4819-64-1-154.
10
Transfer factor in asthma.哮喘中的转移因子
Lancet. 1970 Mar 21;1(7647):626-7. doi: 10.1016/s0140-6736(70)91677-6.

接受白消安治疗的患者的肺功能。

Lung function in patients receiving busulphan.

作者信息

Littler W A, Ogilvie C

出版信息

Br Med J. 1970 Nov 28;4(5734):530-2. doi: 10.1136/bmj.4.5734.530.

DOI:10.1136/bmj.4.5734.530
PMID:5274155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1820065/
Abstract

An attempt was made to achieve earlier detection of busulphan lung (fibrosing alveolitis) and to determine its incidence by means of serial studies during life, including measurement of the gas transfer factor. Twenty-three patients were investigated over an average period of nearly two years of busulphan treatment. One case of busulphan lung was detected and subsequently confirmed at necropsy, but in the remainder there was no clinical, radiological, or physiological evidence of fibrosing alveolitis. It is concluded that the development of fibrosing alveolitis may be related to individual genetic or immunological factors rather than to busulphan dosage.

摘要

研究人员试图通过在患者生前进行系列研究，包括测量气体转移因子，来更早地发现白消安肺（纤维化肺泡炎）并确定其发病率。对23名接受白消安治疗平均近2年的患者进行了调查。检测到1例白消安肺病例，随后尸检得以证实，但其余患者没有纤维化肺泡炎的临床、放射学或生理学证据。得出的结论是，纤维化肺泡炎的发生可能与个体遗传或免疫因素有关，而非白消安剂量。